Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine—Letter

Mohamad B. Sonbol; Thorvardur R. Halfdanarson

doi:10.1158/1078-0432.CCR-20-0443

Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine—Letter

Mohamad B. Sonbol, Thorvardur R. Halfdanarson

Medical Oncology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2433
Number of pages	1
Journal	Clinical Cancer Research
Volume	26
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-20-0443
State	Published - May 15 2020

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-20-0443

Cite this

@article{29b163961b5a41999ca350fda1c93e91,

title = "Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine—Letter",

author = "Sonbol, {Mohamad B.} and Halfdanarson, {Thorvardur R.}",

year = "2020",

month = may,

day = "15",

doi = "10.1158/1078-0432.CCR-20-0443",

language = "English (US)",

volume = "26",

pages = "2433",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - Ipilimumab and Nivolumab in Rare Tumors S1609

T2 - Neuroendocrine—Letter

AU - Sonbol, Mohamad B.

AU - Halfdanarson, Thorvardur R.

PY - 2020/5/15

Y1 - 2020/5/15

UR - http://www.scopus.com/inward/record.url?scp=85084786944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084786944&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-20-0443

DO - 10.1158/1078-0432.CCR-20-0443

M3 - Letter

C2 - 32414760

AN - SCOPUS:85084786944

SN - 1078-0432

VL - 26

SP - 2433

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -

Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine—Letter

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this